Advances in Anti-Seizure Medications

The development of new anti-seizure medications (ASMs) is crucial for improving seizure control and minimizing side effects in individuals with epilepsy. This session will review the latest advancements in ASM research, including the introduction of novel drugs, new formulations, and updated treatment guidelines. Advances in pharmacology and drug delivery systems are enhancing the effectiveness and tolerability of epilepsy treatments.

Research is also focusing on personalized medicine approaches, aiming to tailor ASM therapies to individual patient needs based on genetic and clinical factors. The goal is to provide more effective and individualized treatment options that optimize seizure control while minimizing adverse effects. By staying abreast of these advancements, clinicians can better manage epilepsy and improve patient outcomes.

    Related Conference of Advances in Anti-Seizure Medications

    October 27-28, 2025

    14th International Conference on Herbal Medicine and Acupuncture

    Amsterdam, Netherlands
    November 03-04, 2025

    5th World Medicine Congress

    Rome, Italy
    November 21-22, 2025

    5th International Conference on Medical Research and Development

    Amsterdam, Netherlands
    November 25-26, 2025

    21st World Summit on Blockchain Technology

    Amsterdam, Netherlands
    March 09-10, 2026

    13th World Machine Learning and Deep learning Conference

    Singapore City, Singapore
    March 26-27, 2026

    12th World Congress on Anesthesia and Critical Care

    Amsterdam, Netherlands
    April 20-21, 2026

    47th International Summit on Human Anatomy & Physiology

    Barcelona, Spain
    May 18-19, 2026

    16th Annual Congress on Clinical and Medical Case Reports

    Aix-en-Provence, France
    October 19-20, 2026

    12th World Congress on Medicinal Plants and Marine Drugs

    Aix-en-Provence, France

    Advances in Anti-Seizure Medications Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in